Objective: To assess the variation in HIV-1 over the menstrual cycle, inclu
ding RNA levels in the female genital tract, plasma HIV-1-RNA levels, CD4 c
ell counts, and culturable virus.
Design: A prospective analysis of 55 HIV-1-infected women.
Methods: Blood and genital tract specimens were collected weekly over 8 wee
ks, spanning two complete menstrual cycles. Applying repeated-measures mode
ls that used menses as the reference level, the variation in viral RNA leve
ls was compared in endocervical canal fluid and cells (collected by Sno-str
ips and cytobrush, respectively) and ectocervicovaginal lavage (CVL) fluid.
Repeated-measures models were also used to assess the variation in plasma
CD4 cell counts and viral load.
Results: Shedding patterns differed among the three sampling methods, indep
endent of genital tract co-infections. Genital tract HIV-1-RNA levels from
CVL fluid and endocervical canal cytobrush specimens were highest during me
nses and lowest immediately thereafter (P = 0.001 and P = 0.04). The HIV-I-
RNA level in endocervical canal fluid was highest in the week preceding men
ses(P = 0.003). The menstrual cycle had no effect on blood levels of RNA (P
= 0.62), culturable virus (P = 0.34), or CD4 cell counts (P = 0.55). HIV-I
-RNA levels were higher in endocervical canal fluid than in peripheral bloo
d plasma during the late luteal phase (P = 0.03).
Conclusion: HIV-1-RNA levels vary with the menstrual cycle in the female ge
nital tract but not the blood compartment. HIV-I-RNA levels are higher in e
ndocervical canal fluid than in blood plasma. These findings may have impor
tant implications for sex-specific pathogenesis, heterosexual transmission,
and contraceptive hormone interventions in HIV-l-infected women. (C) 2000
Lippincott Williams & Wilkins.